COLLEGIUM PHARMACEUTICAL, INC (COLL) insider trading

By person

28 insiders · 194 transactions

There is no salary here to measure against. COLLEGIUM PHARMACEUTICAL, INC's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Michael Thomas Heffernan

Director

—

$25.73M (43) scheduled

−$25.73M

50,328

0.1546%

$1.71M

−90.9%

David Hirsch

Director

—

$18.08M (4)

−$18.08M

3,116,956

9.57%

$106.13M

−24.6%

Longitude Capital Partners, LLC entity

10% owner

—

$17.34M (2)

−$17.34M

2,321,842

7.13%

$79.06M

−30.1%

Joseph Ciaffoni

President and CEO

—

$16.93M (40) scheduled

−$16.93M

444,867

1.37%

$15.15M

—

Scott Dreyer

EVP & Chief Commercial Officer

—

$11.58M (31) scheduled

−$11.58M

71,770

0.2205%

$2.44M

—

Shirley R. Kuhlmann

EVP and General Counsel

—

$7.72M (19) scheduled

−$7.72M

108,137

0.3322%

$3.68M

—

Colleen Tupper

EVP & Chief Financial Officer

—

$3.39M (11) scheduled

−$3.39M

147,282

0.4524%

$5.01M

+2,004%

Alison B Fleming

EVP & Chief Technical Officer

—

$1.94M (19) scheduled

−$1.94M

143,694

0.4414%

$4.89M

+1,893%

John A. Fallon

Director

—

$1.65M (1) scheduled

−$1.65M

64,634

0.1985%

$2.20M

+2,621%

Garen G Bohlin

Director

—

$1.26M (2) scheduled

−$1.26M

71,000

0.2181%

$2.42M

—

Thomas B Smith

EVP and Chief Medical Officer

—

$1.06M (3)

−$1.06M

90,651

0.2784%

$3.09M

+3,493%

Rubric Capital Management LP entity

10% owner

—

$946.25K (1)

−$946.25K

3,132,743

9.62%

$106.67M

−0.8%

John Gordon Freund

Director

—

$746.02K (4)

−$746.02K

1,335,400

4.10%

$45.47M

−68.0%

David Dieter

EVP & General Counsel

—

$716.21K (2) scheduled

−$716.21K

77,071

0.2367%

$2.62M

+733.7%

Gino Santini

Director

—

$201.02K (1) scheduled

−$201.02K

112,483

0.3455%

$3.83M

+385.1%

Paul Brannelly

Executive Vice President & CFO

$91.80K (1)

$279.17K (2)

−$187.37K

215,428

0.6617%

$7.34M

+158.4%

Rita J. Balice-Gordon

Director

—

$171.67K (1)

−$171.67K

61,370

0.1885%

$2.09M

—

Nancy Lurker

Director

—

$161.86K (1)

−$161.86K

26,758

0.0822%

$911.11K

—

Yasunori Kaneko

10% owner

—

2,150,186

6.60%

$73.21M

−27.1%

Skyline Venture Partners V LP entity

10% owner

—

2,149,916

6.60%

$73.20M

−27.1%

Vikram Karnani

President and CEO

—

197,864

0.6078%

$6.74M

+52,523%

Richard Malamut

EVP and Chief Medical Officer

—

130,264

0.4001%

$4.44M

—

Gwen A Melincoff

Director

—

52,468

0.1612%

$1.79M

—

Neil F. McFarlane

Director

—

49,365

0.1516%

$1.68M

—

Carlos Paya V

Director

—

28,323

0.0870%

$964.40K

—

Barry S Duke

See remarks

—

20,087

0.0617%

$683.96K

+241.0%

Donovan Michael Glancy

Director

—

17,482

0.0537%

$595.26K

—

Theodore R Schroeder

Director

—

11,007

0.0338%

$374.79K

—

COLLEGIUM PHARMACEUTICAL, INC

What the insiders did Net selling

By person